|
|
Article: French govt gives go-ahead for Boiron-Dolisos merger, but with conditions.
- Article from:
- Pharma Marketletter
- Article date:
- March 7, 2005
CopyrightCOPYRIGHT 2005 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The French Economics and Industry Ministry has given the go-ahead to the merger between the country's main homeopathic drug producers, Boiron and Dolisos (Marketletters passim), but has stipulated that this should be "under certain conditions."
The combined operation will allow Boiron to control at least 85% of the French homeopathic drugs market but the Ministry has not disclosed what conditions are being applied to the deal. This decision follows a favorable view of the merger taken by the country's Competition Council in January this year.
The merger remains subject to approval by the shareholders of both companies at their annual general meetings, ...